Subject
Pathology and Forensic Medicine
Reference40 articles.
1. Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer;Noske;Breast,2021
2. Predictive value of PD-L1 expression to the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer: a systematic review and meta-analysis;Qi,2022
3. Immunotherapy for triple-negative breast cancer: combination strategies to improve outcome;Li,2023
4. Advancing the PD-L1 CPS test in metastatic TNBC: insights from pathologists and findings from a nationwide survey;Fusco;Crit Rev Oncol Hematol,2023
5. Immunotherapy in breast cancer patients: a focus on the use of the currently available biomarkers in Oncology;Criscitiello;Anti Cancer Agents Med Chem,2022